JZJialun Zhu

Jialun Zhu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jialun Zhu has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Resilient nanostructured bioanalytic microneedle longitudinally monitors preclinical renal and hepatic drug clearance and dysfunction

    by Jialun Zhu, Xuanbing Cheng, Mohammadreza Bahramian, Kuanming Yao, Zongqi Li, Bintao Hu, Tsung-Yu Wu, Kiarash A. Sabet, Jiarui Cui, Jiawei Tan, et al.

    Wearable microneedle biosensors promise real-time molecular monitoring for precision medicine but are limited by low sensitivity and tissue abrasion. Overcoming these challenges, we recast electrode functionality not merely as a sensing substrate but as a mechanism for resilient, high signal-to-noise ratio (SNR) measurements in tissue. Our microneedle-based resilient nanostructured bioelectrode (RNB) is fabricated using a bilayer process that strengthens the electrode with a micrometer-thick gold adhesion layer and reduces fabrication-induced stress through controlled dealloying. The resulting RNBs are corrosion resistant, stable over a wide potential window, and have an artifact-free, nanocavity-textured interface. They integrate receptor-based electrochemical biosensors with enhanced SNR through increased active area, diffusion, and antifouling while remaining abrasion immune in megapascal-stiff tissues. The RNB extended in vivo biosensor lifetime for pharmacokinetics monitoring to 6 days in a freely moving rat. Paired with a blood–interstitial fluid equilibrium–based bioanalytical framework, the RNB accurately derived blood-equivalent pharmacokinetic parameters, enabling not only precision dosing of narrow therapeutic index drugs but also the direct assessment of hepatic and renal clearance. In hepatic studies, the RNB revealed delayed clearance of a chemotherapeutic (irinotecan) in liver-damaged models. In renal studies, RNB recordings correlated with blood antibiotic pharmacokinetics across chronic kidney disease severities. The RNB detected renal impairment earlier than conventional biomarker thresholds through drug clearance quantification and captured recovery under therapeutic intervention. These results establish the RNB as a viable microneedle platform for high-fidelity in vivo deployment of electrochemical biosensors, enabling minimally invasive, longitudinal monitoring of low-concentration analytes and real-time assessment of organ function.


  • Non‐Invasive Touch‐Based Lithium Monitoring Using an Organohydrogel‐Based Sensing Interface

    by Shuyu Lin, Jialun Zhu, Justin Yeung, Tsung‐Yu Wu, Xuanbing Cheng, Yichao Zhao, Bo Wang, Jiawei Tan, Sophie Peeters, Ariel Seroussi, et al.

    Lithium is a drug widely employed for the treatment of bipolar disorder owing to its high efficacy in mood management and suicide prevention. However, this efficacy is often undermined by misdosing and nonadherence, and diligent drug monitoring is required during treatment. Standard lithium monitoring involves invasive blood collections and laboratory analysis with low time granularity. Recent advances in sensor technology have enabled the development of personalized drug‐monitoring devices that analyze biomarker information noninvasively. Herein, based on the fact that the analyte partition onto the fingertip with a high flux, a touch‐based noninvasive monitoring modality for managing lithium pharmacotherapy is devised. The system is built based on a thin organohydrogel‐mounted lithium ion‐selective electrode (TOH‐ISE). The TOH coating provides a stable environment for sensing. Through the utilization of a water/glycerol bi‐solvent matrix, the gel exhibits dehydration‐resist properties, rendering a controlled micro‐environment for ISE conditioning, and subsequently minimizing signal drift. To illustrate the clinical application of the solution, the system is tested on a subject prescribed lithium. The system successfully detected the increase in circulating drug levels following medication intake. Collectively, the results indicate the devised solution is capable to facilitate lithium adherence monitoring and has broader potential for optimizing lithium pharmacotherapy.


  • Enhancement of the Short Wavelength Upconversion Emission in Inverse Opal Photonic Crystals

    by Hangjun Wu, Jialun Zhu, Zhengwen Yang, Dong Yan, Rongfei Wang, Jianbei Qiu, Zhiguo Song, Xue Yu, Yong Yang, Dacheng Zhou, et al.

    Upconversion luminescence properties of Yb–Tb codoped Bi4Ti3O12 inverse opals have been investigated. The results show that the upconversion emission can be modulated by the photonic band gap. More significantly, in the upconversion inverse opals, the excited-state absorption of Tb3+ is greatly enhanced by the suppression of upconversion spontaneous emissions of the intermediate excited state, and thus the short wavelength upconversion emission from Tb3+ is considerably improved. We believe that the present work will be valuable for not only the foundational study of upconversion emission modifications but also new optical devices in upconversion displays and short wavelength upconversion lasers.